Concepedia

Matthew J. Armstrong

MJ

Statistics

Publications

68

Citations

7.1K

H-Index

34

Active since

2007

Affiliations

University of Birmingham(Current)

Queen Elizabeth Hospital Birmingham

NIHR Birmingham Liver Biomedical Research Unit

National Institute for Health and Care Research

NIHR Birmingham Biomedical Research Centre

Matthew J. Armstrong is an author at University of Birmingham specializing in medicine, hepatology, and liver disease.

Publications per year

2007–2024

68

Publications

68

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

Matthew J. Armstrong, Piers Gaunt, Guruprasad P. Aithal et al. · The Lancet · 2015 · 2.1K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +5

Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry study

Thomas Marjot, Andrew M. Moon, Jonathan Cook et al. · Journal of Hepatology · 2020 · 525 citations · Full text

Medicine, Immunology, Infectious Diseases +17

Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial

Rohit Loomba, Manal F. Abdelmalek, Matthew J. Armstrong et al. · The Lancet. Gastroenterology & hepatology · 2023 · 472 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis

Matthew J. Armstrong, Diana Hull, Kathy Guo et al. · Journal of Hepatology · 2015 · 447 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension

Dhiraj Tripathi, Adrian J. Stanley, Peter Hayes et al. · Gut · 2020 · 310 citations · Full text

Medicine, Radiology, Gastroenterology +11

1–5 of 68